Fisher & Paykel Healthcare Corporation Limited · NZX:FPH

Fisher & Paykel Healthcare — Shareholder Meeting (2003)

16 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, 2003

  1. Slide 1: Fisher & Paykel Healthcare

    HEALTHCARE § Fisher& Paykel HEALTHCARE

  2. Slide 2: FY03 Highlights

    FY03 Highlights • Record profit NZ$72.9 million • Profit after tax up 17% over last year • Operating revenue up 15% to US$103 million • Core product revenues up 17% in US$ against last year • Operating margin 35.5% for the year 2

  3. Slide 3: Sales by Product

    Sales by Product Neonatal/ Patient Distributed FY03 Warming 4% 6% Obstructive Respiratory Sleep Apnea Humidification 41% 49% 3

  4. Slide 4: Sales by Region

    Sales by Region New Zealand FY03 Australia Other 2% 8% 3% Asia 10% North America 49% Europe 28% 4

  5. Slide 5: Obstructive Sleep Apnea

    _ Obstructive Sleep Apnea yee rw 4 yy He . r : . > Fisher &Paykel HEALTHCARE

  6. Slide 6: Obstructive Sleep Apnea

    Obstructive Sleep Apnea • Revenue (USD) +28%. • Market growing at 15% - 20%. • Improved Medicare reimbursement. 6

  7. Slide 7: New flow generators

    New flow generators HC210 HC220LE 7

  8. Slide 8: Conversion kit

    Conversion kit HC210 Series Conversion Kit 8

  9. Slide 9: Easy conversion to humidity

    Easy conversion to humidity 9

  10. Slide 10: New Aclaim2 mask

    New ~Aclaim2 mask Fisher &Paykel HEALTHCARE

  11. Slide 11: Respiratory Humidification

    Respiratory Humidification 11

  12. Slide 12: Respiratory Humidification

    Respiratory Humidification • Revenue growth (USD) +12% on prior year. • Growing acceptance of MR850 system. • Continued market share growth in breathing circuits. MR850 and Neonatal Breathing Circuits 12

  13. Slide 13: Respiratory Consumables

    Respiratory Consumables Adult Breathing Circuit Neonatal Breathing Circuit Auto-filling chamber Filter 13

  14. Slide 14: Extending the range

    Extending the range Weaning Kit Catheter Mount Non-invasive ventilator breathing circuit 14

  15. Slide 15: Neonatal & Patient Warming

    Neonatal & Patient Warming • Revenue growth (USD) +5%. • Infant bubble CPAP system introduced to most international markets. • Encouraging results with infant bubble CPAP therapy. Bubble CPAP System 15

  16. Slide 16: Fisher & Paykel Healthcare

    SS Fisher &Paykel 1 HEALTHCARE HEALTHCARE

Fisher & Paykel Healthcare — Shareholder Meeting (2003) on 6ix